Compare CMPX & HOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPX | HOV |
|---|---|---|
| Founded | 2014 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 752.4M | 877.2M |
| IPO Year | N/A | N/A |
| Metric | CMPX | HOV |
|---|---|---|
| Price | $5.26 | $133.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | $13.44 | ★ $120.00 |
| AVG Volume (30 Days) | ★ 2.2M | 109.3K |
| Earning Date | 11-05-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 20.64 |
| Revenue | N/A | ★ $3,140,315,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.78 |
| P/E Ratio | ★ N/A | $6.27 |
| Revenue Growth | N/A | ★ 7.83 |
| 52 Week Low | $1.33 | $81.15 |
| 52 Week High | $5.86 | $202.00 |
| Indicator | CMPX | HOV |
|---|---|---|
| Relative Strength Index (RSI) | 63.05 | 61.03 |
| Support Level | $5.13 | $126.50 |
| Resistance Level | $5.86 | $133.22 |
| Average True Range (ATR) | 0.32 | 6.48 |
| MACD | 0.03 | 2.12 |
| Stochastic Oscillator | 52.82 | 94.39 |
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.